Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Body composition, energy expenditure and physical activity

Serum advanced glycation end products are not associated with muscle strength in hemodialysis patients

Abstract

Background

Advanced glycation end products (AGEs) are elevated in patients with renal failure and may potentially affect skeletal muscle. The aim of this study was to evaluate whether serum concentrations of AGEs are associated with muscle strength in hemodialysis (HD) patients, since this association is not clear in the literature.

Methods

This research has a cross-sectional design and included 96 patients on hemodialysis treatment (20–69 years). Serum AGEs (ELISA), three-day dietary records, anthropometric and bioimpedance variables and handgrip strength (HGS) were analysed. Serum AGEs were analyzed by ELISA test.

Results

Men’s HGS were significantly higher than women’s (p < 0.001). Serum AGEs of the individuals of the highest HGS quartile versus the lowest quartile were 11.27 ± 2.52 and 9.06 ± 2.14 (µg/mL), respectively (p = 0.02). After adjustment for potential confounders, the correlation between serum AGEs and HGS lost statistical significance. The main factors that were associated to muscle strength were aging, BMI, percentage of fat-free mass and serum albumin.

Conclusion

Contrary to our hypothesis, serum AGEs were not associated with muscular strength in HD patients. These results suggest that serum AGE is not a good indicator of muscle strength in this population and others factors related to the disease may be more important and significant in reducing muscle strength than the serum concentrations of AGEs alone.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Stevens PE, Adeera L. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825–30.

    Article  Google Scholar 

  2. Sesso RC, Lopes AA, Thomé FS, Lugon JR, Watanabe Y, dos Santos DR. Report of the Brazilian chronic dialysis census 2012. J Bras Nefrol. 2014;36:48–53.

    Article  Google Scholar 

  3. Godfrey AR. Impact of glucose levels on advanced glycation end products in hemodialysis. Hemodial Int. 2007;11:278–85.

    Article  Google Scholar 

  4. Mallipattu SK, He JC, Uribarri J. Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients. Semin Dial. 2012;25:529–38.

    Article  Google Scholar 

  5. Nongnuch A, Davenport A. The effect of vegetarian diet on skin autofluorescence measurements in haemodialysis patients. Br J Nutr. 2015;113:1040–3.

    Article  CAS  Google Scholar 

  6. Poulsen MW, Hedegaard RV, Andersen JM, de Courten B, Bügel S, Nielsen J, et al. Advanced glycation endproducts in food and their effects on health. Food Chem Toxicol. 2013;60:10–37.

    Article  CAS  Google Scholar 

  7. Hegab Z, Gibbons S, Neyses L, Mamas MA. Role of advanced glycation end products in cardiovascular disease. World J Cardiol. 2012;4:90–102.

    Article  Google Scholar 

  8. Barbosa JHP, Oliveira SL, Seara LTE. O papel dos produtos finais da glicação avançada (AGEs) no desencadeamento das complicações vasculares do diabetes. Arq Bras Endocrinol Metabol. 2008;52:940–50.

    Article  Google Scholar 

  9. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129–46.

    Article  CAS  Google Scholar 

  10. De la Maza MP, Uribarri J, Olivares D, Hirsch S, Leiva L, Barrera G, et al. Weight increase is associated with skeletal muscle immunostaining for advanced glycation end products, receptor for advanced glycation end products, and oxidation injury. Rejuvenation Res. 2008;11:1041–8.

    Article  Google Scholar 

  11. Dalal M, Ferrucci L, Sun K, Beck J, Fried LP, Semba RD. Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women. J Gerontol A Biol Sci Med Sci. 2009;64:132–7.

    Article  Google Scholar 

  12. Momma H, Niu K, Kobayashi Y, Guan L, Sato M, Guo H, et al. Skin advanced glycation end product accumulation and muscle strength among adult men. Eur J Appl Physiol. 2011;111:1545–52.

    Article  CAS  Google Scholar 

  13. Mori H, Kuroda A, Araki M, Suzuki R, Taniguchi S, Tamaki M, et al. Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes. J Diabetes Investig. 2017;8:377–82.

    Article  CAS  Google Scholar 

  14. Chiu C-Y, Yang R-S, Sheu M-L, Chan D-C, Yang T-H, Tsai K-S, et al. Advanced glycation end products induce skeletal muscle atrophy and dysfunction in diabetic mice via an RAGE-mediated AMPK-downregulated Akt Pathway. J Pathol. 2016;238:470–82.

    Article  CAS  Google Scholar 

  15. Haus JM, Carrithers JA, Trappe SW, Trappe TA. Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. J Appl Physiol. 2007;103:2068–76.

    Article  CAS  Google Scholar 

  16. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. European working group on sarcopenia in older people: sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39:412–23.

    Article  Google Scholar 

  17. Leal VO, Stockler-Pinto MB, Farage NE, Aranha LN, Fouque D, Anjos LA, et al. Handgrip strength and its dialysis determinants in hemodialysis patients. Nutrition. 2011;27:1125–9.

    Article  Google Scholar 

  18. Leal VO, Mafra D, Fouque D, Anjos LA. Use of handgrip strength in the assessment of the muscle function of chronic kidney disease patients on dialysis: A systematic review. Nephrol Dial Transplant. 2011;26:1354–60.

    Article  Google Scholar 

  19. Browner WS, Newman TB, Hulley S.B. Estimating sample size and power: applications and examples. In: Hulley SB, Browner WS, Grady DG, Newman TB, editors. Designing clinical research, 3rd edn. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 65–94.

  20. Reis MM, Arantes PMM. Medida da força de preensão manual-validade e confiabilidade do dinamômetro saehan. Fisioter e Pesqui. 2011;18:176–81.

    Article  Google Scholar 

  21. Schlüssel MM, dos Anjos LA, de Vasconcellos MTL, Kac G. Reference values of handgrip dynamometry of healthy adults: A population-based study. Clin Nutr. 2008;27:601–7.

    Article  Google Scholar 

  22. Daugirdas JT, Depner TA, Inrig J, Mehrotra R, Rocco MV, Suri RS, et al. National Kidney Foundation: KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis. 2015;66:884–930.

    Article  Google Scholar 

  23. Habitcht JP. Estandarización de métodos epidemiológicos cuantitativos sobre el terreno. Bol Oficina Sanit Panam. 1974;76:375–84.

    Google Scholar 

  24. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, et al. Composition of the ESPEN Working Group. Clin Nutr. 2004;23:1226–43.

    Article  Google Scholar 

  25. Conway J, Ingwersen L, Moshfegh A. Effectiveness of the USDA 5-step multiple-pass method to assess food intake in obese and non-obese women. Am J Clin Nutr. 2003;77:71–78.

    Article  Google Scholar 

  26. Monego E, Peixoto MRG, Santiago R, Gil MF, Cordeiro MM, Campos MI, et al. Alimentos brasileiros e suas porções - Um guia para avaliação do consumo alimentar. Rubio: Rio de Janeiro; 2013. p. 107.

    Google Scholar 

  27. Willett WC, Howe GR, Kushi LW. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:1220S–1228S.

    Article  CAS  Google Scholar 

  28. Pinto AP, Ramos CI, Meireles MS, Kamimura MA, Cuppari L. Impact of hemodialysis session on handgrip strength. J Bras Nefrol. 2015;37:451–7.

    Article  Google Scholar 

  29. Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Baràny P, Heimbürger O, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol. 2014;9:1720–8.

    Article  Google Scholar 

  30. Kittiskulnam P, Chertow GM, Carrero JJ, Delgado C, Kaysen GA, Johansen KL. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int. 2017;92:238–47.

    Article  Google Scholar 

  31. Snow LM, Thompson LV. Influence of insulin and muscle fiber type in nepsilon- (carboxymethyl)-lysine accumulation in soleus muscle of rats with streptozotocin- induced diabetes mellitus. Pathobiology. 2009;76:227–34.

    Article  CAS  Google Scholar 

  32. Thompson LV. Age-related muscle dysfunction. Exp Gerontol. 2009;44:106–11.

    Article  CAS  Google Scholar 

  33. Semba RD, Arab L, Sun K, Nicklett EJ, Ferrucci L. Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults. J Nutr. 2011;141:1726–30.

    Article  CAS  Google Scholar 

  34. Payne GW. Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control. Microcirculation. 2006;13:343–52.

    Article  CAS  Google Scholar 

  35. Bansal S, Chawla D, Siddarth M, Banerjee BD, Madhu SV, Tripathi AK. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications. Clin Biochem. 2013;46:109–14.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the Coordenação de Aperfeiçoamento de Nível Superior (CAPES) for the scholarship and Rodrigo Tallada Iborra (Laboratório de Lipides (LIM 10), Hospital das Clinicas (HCFMUSP) da Faculdade de Medicina da Universidade de Sao Paulo, BR) for measuring serum AGEs. MP received a grant from Fundação de Amparo à Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria do Rosário G. Peixoto.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silva, D.M., Queiroz, N.P., Freitas, A.T.V.S. et al. Serum advanced glycation end products are not associated with muscle strength in hemodialysis patients. Eur J Clin Nutr 73, 617–623 (2019). https://doi.org/10.1038/s41430-018-0379-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41430-018-0379-4

This article is cited by

Search

Quick links